New Chemotherapy Agent LiPyDau Overcomes Drug-Resistant Cancer
Researchers have developed a groundbreaking new chemotherapeutic agent, LiP…
Rising HIV Infections: The Urgent Threat to Ending the Epidemic
More than 40 years have passed since the CDC reported the first cases of H…
Medtech's Role in Supporting Canada's Health Care Providers
Canada's health system is facing significant challenges due to health human re…
Brantford Bulldogs Complete Blockbuster Trade with Oshawa Generals
The Brantford Bulldogs have made the first major trade of the OHL seaso…
National Council of ISACs Webinar
The National Council of ISACs (NCI) will host a webinar on November 5 at 1 PM ET.
The webinar aim…
Thunder GM Sam Presti Shares Update on Nikola Topic's Health
The Oklahoma City Thunder announced that Serbian guard Nikola Topic has been …
Can Agentic Web Browsers Count?
Adam Engst tested Brave, ChatGPT Atlas, Comet, Dia, and Edge on a task of counting minors in event registr…
Navan's IPO Debut Disappoints with 16% Drop
Navan, an expense management platform focused on travel, saw its shares trade at around $21, a…
Longevity Startup Brings Anti-Aging Gene Therapy to Human Trials
Life Biosciences, a Boston-based biotech company founded by Harvard profe…
Berkeley Council Votes to Allow Police Scanner Encryption
Opponents of full encryption have expressed concerns that the public will lose a…